The past 12 months recorded several medical breakthroughs, including first-time gene therapy outcomes, notable FDA approvals and virtual healthcare delivery, ABC News reported Dec. 30. Here are seven ...
Avvio Medical, Inc., a clinical-stage medical device company developing next-generation kidney stone treatment technologies, today announced that the U.S. Food and Drug Administration (FDA) has ...
On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results